Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium Effects on Bleeding in Pediatric Tonsillectomy
NCT06399445Phase 4Recruiting
- Sponsor
- Clinical Hospital Center Split
- Start
- Apr 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rocuronium in recurrent tonsillitis, obstructive sleep apnea (OSA), sponsored by Clinical Hospital Center Split. Started Apr 2024; status: recruiting.
02
Drugs
rocuronium
03
Conditions
recurrent tonsillitisobstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06399445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06399445.